Onkure Therapeutics, Inc. · NASDAQ:OKUR
The Vanguard Group's stake in Onkure Therapeutics, Inc. fell to 4.87% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group's stake in Onkure Therapeutics, Inc. fell to 4.87%, 626,593 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 4.87%
- Shares
- 626,593
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.87% | 626,593 |
Source
Related
- Onkure Therapeutics, Inc.
- The Vanguard Group
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · The Vanguard Group · Jan 31, 2025
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026